You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
健民集團(600976.SH):武漢生產地擴建綜合製劑車間二樓D區顆粒製劑生產線(二)通過藥品GMP符合性檢查
格隆匯 12-02 15:36

格隆匯12月2日丨健民集團(600976.SH)公佈,公司近期武漢生產地擴建綜合製劑車間二樓D區顆粒製劑生產線(二)通過藥品GMP符合性檢查,並完成《藥品生產許可證》的變更備案,生產地址和生產範圍:

1、湖北省武漢市漢陽區鸚鵡大道484號:顆粒劑、散劑、丸劑(蜜丸、水蜜丸、水丸、濃縮丸、糊丸)、片劑、硬膠囊劑、糖漿劑、煎膏劑(膏滋)、膜劑、口服溶液劑(含中藥提取車間)。

2、受託方:健民集團葉開泰國藥(隨州)有限公司;生產地址:湖北省隨州市高新技術產業園區;生產範圍:片劑、硬膠囊劑、糖漿劑、煎膏劑(膏滋)、顆粒劑。

本次《藥品生產許可證》變更備案是基於公司武漢生產基地擴建生產線通過藥品GMP符合性檢查,將有利於公司提高生產能力,確保市場供應,公司本次生產線通過藥品GMP符合性檢查對公司未來生產經營產生積極影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account